{"title":"Probiotics in the NICU: a personal practice","authors":"Sybil Barr","doi":"10.1016/j.paed.2024.10.006","DOIUrl":null,"url":null,"abstract":"<div><div>There is increasing interest in the use of probiotics in preterm infants in NICUs to reduce intestinal dysbiosis and subsequently reduce morbidity in these vulnerable neonates. However, heterogenicity of organisms used in various trials has meant definitive evidence is still not available to make strong recommendations and probiotic use remains varied.</div></div>","PeriodicalId":38589,"journal":{"name":"Paediatrics and Child Health (United Kingdom)","volume":"35 1","pages":"Pages 34-35"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Paediatrics and Child Health (United Kingdom)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1751722224001604","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
There is increasing interest in the use of probiotics in preterm infants in NICUs to reduce intestinal dysbiosis and subsequently reduce morbidity in these vulnerable neonates. However, heterogenicity of organisms used in various trials has meant definitive evidence is still not available to make strong recommendations and probiotic use remains varied.